Amir Reihani Selected Research

Dyslipidemias (Dyslipidemia)

1/2022

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Reihani Research Topics

Disease

2	Fibrosis (Cirrhosis) 01/2023 - 01/2021
2	Endometriosis 01/2023 - 01/2022
2	Lung Injury 01/2023 - 01/2021
1	Choristoma (Ectopic Tissue) 01/2023
1	Neoplasms (Cancer) 06/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Hypothermia 01/2022
1	Infections 01/2022
1	Human Influenza (Influenza) 01/2022
1	Viral Pneumonia 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Lung Diseases (Lung Disease) 01/2021

Drug/Important Bio-Agent (IBA)

2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 01/2021
2	SmokeIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Activating Transcription Factor 6IBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	Acetyl-CoA CarboxylaseIBA 01/2022
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021

Therapy/Procedure

1	Oncolytic Virotherapy 06/2022
1	Therapeutics 01/2022